Intrapleural chemo- and hyperthermotherapies for malignant pleural effusion: A randomized prospective study

Cancer Investigation

Volumn 30, Issue 2, 2012, Pages 126-130

  Chen, Wen Jun ^a   Yuan, Shao Fei ^a   Yan, Qing Yuan ^b   Xiong, Jian Ping ^c   Wang, Sen Ming ^d   Zheng, Wei E ^a   Zhang, Wu ^a   Sun, Hong Yu ^a   Chen, Hua ^a   Wu, Li Li ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b People's Hospital   (China)

^c NANCHANG UNIVERSITY   (China)

^d SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Cisplatin; Hyperthermotherapy; Intrapleural chemotherapy; Malignant pleural effusion; OK 432

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOCETAXEL; EPIRUBICIN; FLUOROURACIL; FOLINATE CALCIUM; GEMCITABINE; IRINOTECAN; NAVELBINE; OXALIPLATIN; PACLITAXEL; PEMETREXED; PICIBANIL;

ADULT; ANOREXIA; ARTICLE; BONE MARROW DEPRESSION; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTHERMIC THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PLEURA EFFUSION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME; TREATMENT OUTCOME; VOMITING;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; LUNG NEOPLASMS; MALE; MIDDLE AGED; PICIBANIL; PLEURAL EFFUSION, MALIGNANT; PROSPECTIVE STUDIES; QUALITY OF LIFE; SURVIVAL ANALYSIS;

EID: 84862966643     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2011.633292     Document Type: Article

References (38)

1. Pace E, Siena L, Ferraro M, Profita M, Mondello P, Chiappara G, Montalbano AM, Giarratano A, Bonsignore G, Gjomarkaj M. Role of prostaglandin E2 in the invasiveness, growth and protection of cancer cells in malignant pleuritis. Eur J Cancer 2006;42:2382-2389. (Pubitemid 44307619)
2. Figlin R, Mendoza E, Piantadosi S, Rusch V. Intrapleural chemotherapy without pleurodesis for malignant pleural effusions. LCSG Trial 861. Chest 1994;106:363S-366S. (Pubitemid 24370976)
3. American Thoracic Society. Management of malignant pleural effusions. Am J Respir Crit Care Med 2000;162:1987-2001.
4. Sahn SA. Malignancy metastatic to the pleura. Clin Chest Med 1998;19:351-361. (Pubitemid 28277882)
5. Sahn SA. Pleural diseases related to metastatic malignancies. Eur Respir J 1997;10:1907-1913. (Pubitemid 27368388)
6. Livingston RB, McCracken JD, Trauth CJ, Chen T. Isolated pleural effusion in small cell lung carcinoma: favorable prognosis. A review of the Southwest Oncology Group experience. Chest 1982;81:208-211. (Pubitemid 12143672)
7. Tan C, Sedrakyan A, Browne J, Swift S, Treasure T. The evidence on the effectiveness ofmanagement for malignant pleural effusion: A systematic review. Eur J Cardiothorac Surg 2006;29:829-838.
8. Neragi-Miandoab S. Malignant pleural effusion, current and evolving approaches for its diagnosis and management. LungCancer 2006;54:1-9.
9. Musani AI. Treatment options for malignant pleural effusion. Curr Opin Pulm Med 2009;15:380-387.
10. Ishida A,Miyazawa T,Miyazu Y, Iwamoto Y, Zaima M, Kanoh K, SumiyoshiH,Doi M. Intrapleural cisplatin andOK432 therapy for malignant pleural effusion caused by non-small cell lung cancer. Respirology 2006;11:90-97.
11. Kataoka M, Morishita R, Hiramatsu J, Ueoka H, Nakata Y, Ohnoshi T, Kimura I, Harada M. OK-432 induces production of neutrophil chemotactic factors in malignant pleural effusion. Intern Med 1995;34:352-356.
12. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-214. (Pubitemid 11167383)
13. Stahel RA, Speak JA, Bernal SD. Murine monoclonal antibody LAM2 defines cell membrane determinant with preferential expression on human lung small-cell carcinoma and squamous-cell carcinomas. Int J Cancer 1985;35:11-17. (Pubitemid 15009634)
14. Putnam JB Jr, Light RW, Rodriguez RM, Ponn R, Olak J, Pollak JS, Lee RB, Payne DK, Graeber G, Kovitz KL. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer 1999;86:1992-1999.
15. Du Z, Zhou Y, Yang P. Sulfur dioxide derivatives increase a hyperpolarization-activated inward current in dorsal root ganglion neurons. Toxicology 2007;239:180-185. (Pubitemid 47347966)
16. Lombardi G, Zustovich F, Nicoletto MO, Donach M, Artioli G, Pastorelli D. Diagnosis and treatment of malignant pleural effusion: A systematic literature review and new approaches. AmJ Clin Oncol 2010;33:420-423.
17. Ichinose Y, Yano T, Asoh H, Yokoyama H, Fukuyama Y, Miyagi J, Kuninaka S, Terazaki Y. Intraoperative intrapleural hypotonic cisplatin treatment for carcinomatous pleuritis. J Surg Oncol 1997;66:196-200. (Pubitemid 27476036)
18. Luh KT, Yang PC, Kuo SH, Chang DB, Yu CJ, Lee LN. Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. A randomized trial. Cancer 1992;69:674-679.
19. KimuraM, Tojo T,Naito H, Nagata Y, KawaiN, Taniguchi S. Effects of a simple intraoperative intrathoracic hyperthermotherapy for lung cancer with malignant pleural effusion or dissemination. Interact Cardiovasc Thorac Surg 2010;10:568-571.
20. Tattersall MH, Boyer MJ. Management of malignant pleural effusions. Thorax 1990;45:81-82. (Pubitemid 20067999)
21. Spiegler PA, Hurewitz AN, Groth ML. Rapid pleurodesis for malignant pleural effusions. Chest 2003;123:1895-1898. (Pubitemid 36706709)
22. Cascinu S, Isidori PP, Fedeli A, Fedeli SL, Raspugli M, Rossi A, Ugolini M, Catalano G. Experience with intrapleural natural beta interferon in the treatment of malignant pleural effusions. Tumori 1991;77:237-238.
23. Rosso R, Rimoldi R, Salvati F, De Palma M, Cinquegrana A, Nicolo G, Ardizzoni A, Fusco U, Capaccio A, Centofanti R, Neri M, Cruciani A, Maisto. Intrapleural natural beta interferon in the treatment of malignant pleural effusions. Oncology 1988;45:253-256.
24. Gebbia N,Mannino R, Di Dino A,Maxhouni L, BelloneN, Cinque L, Liuzza A, La Motta P, Cannata G, Gulotta G, Gebbia V. Intracavitary treatment of malignant pleural and peritoneal effusions in cancer patients. Anticancer Res 1994;14:739-745. (Pubitemid 24172202)
25. Goldman CA, Skinnider LF, Maksymiuk AW. Interferon instillation for malignant pleural effusions. Ann Oncol 1993;4:141-145. (Pubitemid 23061315)
26. WilkinsHE III,ConnollyMM,Grays P,Marquez G,Nelson D. Recombinant interferon alpha-2b in the management of malignant pleural effusions. Chest 1997;111:1597-1599. (Pubitemid 27260089)
27. Antoniou KM, Ferdoutsis E, Bouros D. Interferons and their application in the diseases of the lung. Chest 2003;123:209-216. (Pubitemid 36126734)
28. Kawano M, Miura H, Anan H, Shimizu M. Treatment of secondary spontaneous pneumothorax complicating silicosis and progressive massive fibrosis. Kurume Med J 2002;49:35-40.
29. Uchida A, Micksche M. Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated byOK432. JNatl Cancer Inst 1983;71:673-680. (Pubitemid 14232379)
30. Katano M,Morisaki T. The past, the present and future of the OK- 432 therapy for patients with malignant effusions. Anticancer Res 1998;18:3917-3925. (Pubitemid 28561081)
31. Wei Y, Zhao X, Kariya Y, Fukata H, Teshigawara K, Uchida A. Induction of autologous tumor killing by heat treatment of fresh human tumor cells: Involvement of gamma delta T cells and heat shock protein 70. Cancer Res 1996;56:1104-1110. (Pubitemid 26065407)
32. Rusch VW, Figlin R, Godwin D, Piantadosi S. Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: A Lung Cancer Study Group trial. J Clin Oncol 1991;9:313-319.
33. Tohda Y, Iwanaga T, Takada M, Yana T, Kawahara M, Negoro S, Okishio K, Kudoh S, FukuokaM, Furuse K. Intrapleural administration of cisplatin and etoposide to treat malignant pleural effusions in patients with non-small cell lung cancer. Chemotherapy 1999;45:197-204. (Pubitemid 29213402)
34. Su WC, Lai WW, Chen HH, Hsiue TR, Chen CW, Huang WT, Chen TY, Tsao CJ, Wang NS. Combined intrapleural and intravenous chemotherapy, and pulmonary irradiation, for treatment of patients with lung cancer presenting with malignant pleural effusion. A pilot study. Oncology 2003;64:18-24. (Pubitemid 35477950)
35. Monjanel-Mouterde S, Frenay C, Catalin J, Boutin C, Durand A, Astoul P. Pharmacokinetics of intrapleural cisplatin for the treatment of malignant pleural effusions. Oncol Rep 2000;7:171-175.
36. Storm FK. Clinical hyperthermia and chemotherapy. Radiol Clin North Am 1989;27:621-627.
37. Walker-Renard PB, Vaughan LM, Sahn SA. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med 1994;120:56-64. (Pubitemid 24011502)
38. Guirgis MF, Lueder GT. Choroidal neovascular membrane associated with optic nerve coloboma in a patient with CHARGE association. Am J Ophthalmol 2003;135:919-920. (Pubitemid 36677426)